rs200520956
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_021098.3(CACNA1H):āc.809A>Cā(p.Asn270Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000603 in 1,596,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1H | NM_021098.3 | c.809A>C | p.Asn270Thr | missense_variant | 7/35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.809A>C | p.Asn270Thr | missense_variant | 7/35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000565831.6 | c.809A>C | p.Asn270Thr | missense_variant | 6/33 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000638323.1 | c.770A>C | p.Asn257Thr | missense_variant | 7/35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000639478.1 | n.809A>C | non_coding_transcript_exon_variant | 7/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.809A>C | non_coding_transcript_exon_variant | 7/35 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000346 AC: 80AN: 231174Hom.: 0 AF XY: 0.000372 AC XY: 47AN XY: 126254
GnomAD4 exome AF: 0.000630 AC: 910AN: 1444248Hom.: 0 Cov.: 31 AF XY: 0.000592 AC XY: 424AN XY: 716050
GnomAD4 genome AF: 0.000342 AC: 52AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74442
ClinVar
Submissions by phenotype
CACNA1H-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 24, 2023 | The CACNA1H c.809A>C variant is predicted to result in the amino acid substitution p.Asn270Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.068% of alleles in individuals of European (Non-Finnish) descent in gnomAD (https://gnomad.broadinstitute.org/variant/chr16-1250261-A-C). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.809A>C (p.N270T) alteration is located in exon 7 (coding exon 6) of the CACNA1H gene. This alteration results from a A to C substitution at nucleotide position 809, causing the asparagine (N) at amino acid position 270 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at